Latest Trials

EudraCT Number: 2006-000685-36 Sponsor Protocol Number: EMR 200025 – 001 Start Date: 2006-11-29
Sponsor Name: Merck KGaA
Full Title: A randomized, open-label phase II study evaluating the efficacy and safety of FOLFOX-4 plus cetuximab versus UFOX plus cetuximab as first-line therapy in subjects with metastatic colorectal cancer
Medical condition: Metastatic colorectal cancer
Disease: Version SOC Term Classification Code Term Level
8.1 10052362 Metastatic colorectal cancer LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: AT (Completed) FR (Completed) BE (Completed) GR (Completed) DE (Completed) IT (Completed)
Trial results: View results
EudraCT Number: 2006-003087-59 Sponsor Protocol Number: EFC6193 Start Date: 2006-11-29
Sponsor Name: sanofi aventis recherche et developpement
Full Title: A Randomized, Open Label Multi-Center Study of XRP6258 At 25 mg/m2 in Combination With Prednisone Every 3 Weeks Compared To Mitoxantrone in Combination With Prednisone For The Treatment of Hormone ...
Medical condition: Hormone Refractory Metastatic Prostate Cancer
Disease: Version SOC Term Classification Code Term Level
8.1 10062904 Hormone-refractory prostate cancer LLT
Population Age: Adults, Elderly Gender: Male
Trial protocol: CZ (Completed) DE (Completed) HU (Completed) BE (Completed) NL (Completed) SK (Completed) DK (Completed) SE (Completed) FI (Completed) IT (Completed) GB (Completed)
Trial results: View results
EudraCT Number: 2006-004442-16 Sponsor Protocol Number: cro524 Start Date: 2006-11-29
Sponsor Name: Imperial College London
Full Title: Modulation of lung injury complicating lung resection
Medical condition: Acute respiratory distress syndrome, Acute Lung Injury, Ventilator-Induced Lung Injury
Disease: Version SOC Term Classification Code Term Level
8.1 10001052 Acute respiratory distress syndrome LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2006-004517-17 Sponsor Protocol Number: CGX-635-AML-204 Start Date: 2006-11-29
Sponsor Name: Stragen France
Full Title: A Phase II Open-Label Study of the Subcutaneous Administration of Homoharringtonine (CGX-635) in the Treatment of Refractory or Relapsed Acute Myeloid Leukemia (AML)
Medical condition: Acute Myeloid Leukaemia
Disease: Version SOC Term Classification Code Term Level
8.1 10000886 Acute myeloid leukemia LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)
EudraCT Number: 2006-003108-20 Sponsor Protocol Number: DM04RUP/IV/05 Start Date: 2006-11-29
Sponsor Name: URIACH J. URIACH Y COMPANIA S.A.
Full Title: A DOUBLE BLIND, RANDOMISED, PARALLEL, PLACEBO-CONTROLLED, PILOT STUDY TO EVALUATE THE ANTI-INFLAMMATORY EFFECTS AND THE EFFICACY OF RUPATADINE 10 MG ON THE SYMPTOMS OF PERSISTENT ALLERGIC RHINITIS
Medical condition: PAR
Disease: Version SOC Term Classification Code Term Level
6.1 10039085 PT
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: (No results available)
EudraCT Number: 2006-005558-63 Sponsor Protocol Number: V70P3 Start Date: 2006-11-28
Sponsor Name: Novartis Vaccines and Diagnostics S.r.l.
Full Title: A phase III, randomized, controlled, observer-blind, single-center study to compare immunogenicity and safety of an MF59-adjuvanted inactivated subunit influenza vaccine (FLUAD™) to those of a nona...
Medical condition: Influenza
Disease: Version SOC Term Classification Code Term Level
18.1 10021881 - Infections and infestations 10022000 Influenza PT
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2006-004222-93 Sponsor Protocol Number: GPE 02 Start Date: 2006-11-28
Sponsor Name: Curalogic A/S
Full Title: Assessment of the Maximal Tolerated Dose of a Microencapsulated Grass (Phleum pratense) Pollen Extract (MGPE) in Subjects with Grass Pollen Allergy in a Randomized, Double-Blind, Placebo-Controlled...
Medical condition: Treatment of seasonal allergic rhinitis to grass pollen.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: (No results available)
EudraCT Number: 2006-004775-35 Sponsor Protocol Number: ESA-2 Start Date: 2006-11-28
Sponsor Name: Barts and the London NHS Trust
Full Title: The Effect of Treating Patients with Anaemia in Diabetic Nephropathy to different target haemoglobin levels with Epoetin Beta
Medical condition: Anaemia in Diabetic Nephropathy
Disease: Version SOC Term Classification Code Term Level
8.1 10002071 Anaemia NOS LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2006-003163-31 Sponsor Protocol Number: AI424-328 Start Date: 2006-11-28
Sponsor Name: Bristol-Myers Squibb International Corporation
Full Title: Open-Label, Multiple-Dose, Drug Interaction Study to Assess the Effect of Famotidine with or without Tenofovir on the Pharmacokinetics of Atazanavir when given with Ritonavir in HIV-Infected Subjec...
Medical condition: HIV infected Subjects
Disease: Version SOC Term Classification Code Term Level
8.1 10020161 HIV infection LLT
Population Age: Adults Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2006-005609-76 Sponsor Protocol Number: SSAT 018 Start Date: 2006-11-28
Sponsor Name: St Stephens Aids Trust
Full Title: EFFECT OF DIFFERENT MEALS ON THE PHARMACOKINETIC PROFILE OF SAQUINAVIR AT STEADY STATE IN HIV-INFECTED PATIENTS TREATED WITH SAQUINAVIR/RITONAVIR 1000/100 mg BID.
Medical condition: HIV
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe